Search - tctmd.com

Displaying 1 - 20 of 172

Sort: Relevancy | Date

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Todd Neale

December 26, 2025

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Daily News

Philips Recalls Tack Endovascular Systems and Stops Distribution

L.A. McKeown

March 03, 2025

News Daily News

Survey Calls Out Implicit Bias in Peripheral Vascular Care

L.A. McKeown

February 28, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2025

Shelley Wood

February 28, 2025

News Daily News

AHA Scientific Statement Takes Aim at PAD Pain

L.A. McKeown

February 13, 2025

News Daily News

FDA Issues Early Alert About Risks of Peripheral Atherectomy Device

L.A. McKeown

February 07, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Presentation TCT 2024

Clinical Outcomes of Stent Versus Non-Stent Interventions for Symptomatic Infrainguinal Peripheral Artery Disease in the Excellence in Peripheral Artery Disease (XLPAD) Registry

Presenter: Subhash Banerjee

October 28, 2024

Presentation TCT 2024

TCT 397: Comparative Outcomes of Below-the-Knee CTO vs Non-CTO Peripheral Artery Interventions From the XLPAD Registr

Presenter: Minseob Jeong

October 27, 2024

Presentation TCT 2024

TCT 30: Comparative Outcomes of Non-Stent Below-the-Knee Peripheral Artery Interventions in Critical Limb Threatening Ischemia vs Intermittent Claudication From the XLPAD Registry

Presenter: Minseob Jeong

October 27, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

Advertisement

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

December 2025 Dispatch for the CV Team

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

Philips Recalls Tack Endovascular Systems and Stops Distribution

Survey Calls Out Implicit Bias in Peripheral Vascular Care

TCTMD’s Top 10 Most Popular Stories for February 2025

AHA Scientific Statement Takes Aim at PAD Pain

FDA Issues Early Alert About Risks of Peripheral Atherectomy Device

Top Endovascular News of 2024

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

Clinical Outcomes of Stent Versus Non-Stent Interventions for Symptomatic Infrainguinal Peripheral Artery Disease in the Excellence in Peripheral Artery Disease (XLPAD) Registry

TCT 397: Comparative Outcomes of Below-the-Knee CTO vs Non-CTO Peripheral Artery Interventions From the XLPAD Registr

TCT 30: Comparative Outcomes of Non-Stent Below-the-Knee Peripheral Artery Interventions in Critical Limb Threatening Ischemia vs Intermittent Claudication From the XLPAD Registry

September 2024 Dispatch for the CV Team

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content